Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
OSCR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-0.07
vs -0.53
Q3.23
N/A
-0.29
vs -0.91
Q4.23
N/A
-0.66
vs -1.05
Q1.24
+444%
0.62
vs -0.18
Q2.24
+386%
0.2
vs -0.07
Q3.24
N/A
-0.22
vs -0.29
Q4.24
N/A
-0.62
vs -0.66
Q1.25
+48%
0.92
vs 0.62
Q2.25
+66%
0.33
vs 0.2
Q3.25
N/A
-0.10
vs -0.22
Sales Growth
YoY
Current
Estimates
Q2.23
+44%
1.5B vs 1.1B
Q3.23
+3492%
1.4B vs 40.1M
Q4.23
+38%
1.4B vs 1B
Q1.24
+46%
2.1B vs 1.5B
Q2.24
+46%
2.2B vs 1.5B
Q3.24
+68%
2.4B vs 1.4B
Q4.24
+67%
2.4B vs 1.4B
Q1.25
+42%
3B vs 2.1B
Q2.25
+29%
2.9B vs 2.2B
Q3.25
+14%
2.8B vs 2.4B
Return on Equity
QoQ
Q2.23
-2%
-0.02
vs -0.04
Q3.23
-7%
-0.07
vs -0.02
Q4.23
-19%
-0.19
vs -0.07
Q1.24
+17%
0.17
vs -0.19
Q2.24
+5%
0.05
vs 0.17
Q3.24
-5%
-0.05
vs 0.05
Q4.24
-15%
-0.15
vs -0.05
Q1.25
+21%
0.21
vs -0.15
Institutionnal Ownership
QoQ
Q2.23
168
168
vs 135
24%
Q3.23
183
183
vs 168
9%
Q4.23
197
197
vs 183
8%
Q1.24
235
235
vs 197
19%
Q2.24
281
281
vs 235
20%
Q3.24
305
305
vs 281
9%
Q4.24
284
284
vs 305
-7%
Q1.25
313
313
vs 284
10%
seekingalpha.com
1 hour ago
fool.com
5 hours ago
zacks.com
8 hours ago
seekingalpha.com
10 hours ago
seekingalpha.com
14 hours ago
youtube.com
18 hours ago
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
NYSE
EPS improving
EPS improving
Relative Strenght
30
Volume Buzz
32%
Earning Acce
No
Dist 52w H.
42%Forecast
260%2026-Revenue
-9%2026-EPS
-912%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
UBS
initialisePrevious: Not converted
2024-10-07
Now: Neutral
Piper Sandler
initialisePrevious: Not converted
2024-06-25
Now: Overweight
Bank of America Securities
upgradePrevious: Not converted
2023-06-06
Now: Neutral
Wells Fargo
upgradePrevious: Not converted
2022-11-15
Now: Overweight
Quote Panel
Key Metrics
Relative Strength
OSCR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|